Felzartamab in late ABMR

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511764-86-00

Enrollment

Registered

2024-12-11

Start date

2021-09-07

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

late antibody mediated renal transplant rejection

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026